Correlation Between Norsk Hydro and Nykode Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Norsk Hydro and Nykode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Norsk Hydro and Nykode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Norsk Hydro ASA and Nykode Therapeutics ASA, you can compare the effects of market volatilities on Norsk Hydro and Nykode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Norsk Hydro with a short position of Nykode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Norsk Hydro and Nykode Therapeutics.

Diversification Opportunities for Norsk Hydro and Nykode Therapeutics

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Norsk and Nykode is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Norsk Hydro ASA and Nykode Therapeutics ASA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nykode Therapeutics ASA and Norsk Hydro is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Norsk Hydro ASA are associated (or correlated) with Nykode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nykode Therapeutics ASA has no effect on the direction of Norsk Hydro i.e., Norsk Hydro and Nykode Therapeutics go up and down completely randomly.

Pair Corralation between Norsk Hydro and Nykode Therapeutics

Assuming the 90 days trading horizon Norsk Hydro ASA is expected to generate 0.43 times more return on investment than Nykode Therapeutics. However, Norsk Hydro ASA is 2.34 times less risky than Nykode Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Nykode Therapeutics ASA is currently generating about -0.09 per unit of risk. If you would invest  7,168  in Norsk Hydro ASA on September 1, 2024 and sell it today you would lose (338.00) from holding Norsk Hydro ASA or give up 4.72% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Norsk Hydro ASA  vs.  Nykode Therapeutics ASA

 Performance 
       Timeline  
Norsk Hydro ASA 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Norsk Hydro ASA are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting basic indicators, Norsk Hydro disclosed solid returns over the last few months and may actually be approaching a breakup point.
Nykode Therapeutics ASA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nykode Therapeutics ASA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Norsk Hydro and Nykode Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Norsk Hydro and Nykode Therapeutics

The main advantage of trading using opposite Norsk Hydro and Nykode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Norsk Hydro position performs unexpectedly, Nykode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nykode Therapeutics will offset losses from the drop in Nykode Therapeutics' long position.
The idea behind Norsk Hydro ASA and Nykode Therapeutics ASA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes